Drug Pricing

The Good, The Bad, And The Ugly From Brown's Pen

Submitted by Liza Tucker on Tue, 10/17/2017 - 12:46

Consumers looking for bold action this year on laws protecting their wallets from rapacious drug companies, their privacy from the prying eyes of telecom companies, and their environment from the degradation of the oil and gas industry, didn't get any. But they did get some legislation that helps them take banks to court for fraud and to follow the money behind political ads.

The Ugly:

Tags: 

End Of Session Hijinks Leave Consumers In Cold

Submitted by Jamie Court on Sat, 09/16/2017 - 07:47

As the legislature ended its business for the year in the early morning hours, legislative leaders proclaimed a prolific progressive session.  Not so if you care about consumer protection.
 
Key public interest causes were abandoned because of the power of the usual moneyed interest groups and the dependency of state house politicians on them.
 

Tags: 

Kaiser Family Foundation Gives Stage to Opponents of Prop 61's Drug Pricing Reform

Submitted by Carmen Balber on Wed, 10/05/2016 - 17:37

What do supporters of drug price negotiation have to say when the pharmaceutical industry tries to shoot down drug pricing reforms?

You'd never know if you were watching Tuesday's webcast on prescription drugs and “Election-Cycle Proposals for Lowering Costs” hosted by the Kaiser Family Foundation (KFF) charity, which runs the nonprofit news service Kaiser Health News.

Tags: 

Can Drugmaking Goliath's $100 Million War Chest Stop David's Rx Relief Ballot Measure?

Submitted by Jamie Court on Tue, 05/17/2016 - 12:58

Big Pharma has put up $100 million to stop a ballot measure aimed at reining in California's prescription drug tab. Will $100 million be enough to stop a ballot measure that goes to the heart of the Bernie Sanders revolution?

Tags: 

Big Pharma Fattening Coffers to Stop Drug Price Reduction Initiative

Submitted by Eddie Barrera on Fri, 12/18/2015 - 14:03
Big Pharma fears only one thing: a government regulator who will push back on drug prices and protect consumers. Its fears could be realized in a year if an initiative intended to lower drug prices is approved by voters, which is why the drug companies have already filled a campaign war chest with nearly $40 million.
 

Tags: 

Capitol Watchdog is owned and operated by nonprofit Consumer Watchdog. For more information about Consumer Watchdog visit http://www.consumerwatchdog.org